Meng Tong

机构：Kaiser Permanente, Kaiser Permanente Santa Clara Medical Center · ORCID：0000-0001-8244-0277

发表论文 39 篇 · 总被引 593 次 · h-index 11

代表论文

PI3K alpha and delta promote hematopoietic stem cell activation (2019 · JCI Insight · 被引 42)
PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells (2023 · Science Advances · 被引 18)
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms (2022 · Clinical Cancer Research · 被引 2)
RON Kinase Is a Novel Therapeutic Target for Philadelphia-Negative Myeloproliferative Neoplasms (2021 · Blood · 被引 1)
Class I PI3K Is Required for HSC Differentiation (2019 · Blood · 被引 1)
Supplementary Data 3 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms (2025)